Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R.

N Engl J Med. 2003 Mar 6;348(10):883-90. Erratum in: N Engl J Med. 2003 May 8;348(19):1939.

2.

A randomized trial of aspirin to prevent colorectal adenomas.

Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU.

N Engl J Med. 2003 Mar 6;348(10):891-9.

3.

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.

Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER.

N Engl J Med. 1999 Jan 14;340(2):101-7.

4.

Celecoxib for the prevention of colorectal adenomatous polyps.

Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B; PreSAP Trial Investigators.

N Engl J Med. 2006 Aug 31;355(9):885-95.

5.

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):256-66. doi: 10.1093/jnci/djn485. Epub 2009 Feb 10.

PMID:
19211452
6.

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators.

N Engl J Med. 2005 Mar 17;352(11):1092-102. Epub 2005 Feb 15. Erratum in: N Engl J Med. 2006 Jul 13;355(2):221.

7.

Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR; ukCAP Trial Group.

Gastroenterology. 2008 Jan;134(1):29-38. Epub 2007 Oct 10.

PMID:
18022173
8.

Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

Alberts DS, Martínez ME, Roe DJ, Guillén-Rodríguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE.

N Engl J Med. 2000 Apr 20;342(16):1156-62.

9.

Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.

Asano TK, McLeod RS.

Dis Colon Rectum. 2004 May;47(5):665-73. Epub 2004 Apr 2. Review.

PMID:
15054679
10.

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S, Morton DG; APPROVe Trial Investigators.

Gastroenterology. 2006 Dec;131(6):1674-82. Epub 2006 Sep 1.

PMID:
17087947
11.

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.

Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S.

Gastroenterology. 2003 Aug;125(2):328-36.

PMID:
12891533
12.

Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks.

J Natl Cancer Inst. 2005 Jun 1;97(11):846-53.

PMID:
15928305
13.

Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas.

MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, Gratten H, Lambert J, Newland RC, Ngu M, Russell A, Ward M, Wahlqvist ML; Australian Polyp Prevention Project.

J Natl Cancer Inst. 1995 Dec 6;87(23):1760-6.

PMID:
7473832
14.

Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.

Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT.

Gastroenterology. 1998 Mar;114(3):441-7.

PMID:
9496933
15.

Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.

Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J.

N Engl J Med. 2000 Apr 20;342(16):1149-55.

16.

High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening.

Kahi CJ, Anderson JC, Waxman I, Kessler WR, Imperiale TF, Li X, Rex DK.

Am J Gastroenterol. 2010 Jun;105(6):1301-7. doi: 10.1038/ajg.2010.51. Epub 2010 Feb 23.

PMID:
20179689
17.

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.

Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD, Haile RW, et al.

N Engl J Med. 1994 Jul 21;331(3):141-7.

18.

Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicentre Study Group.

Gut. 2001 Jun;48(6):812-5.

19.
20.

Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial.

Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, Beck GJ, Greenberg ER.

J Natl Cancer Inst. 2003 May 21;95(10):717-22.

PMID:
12759389

Supplemental Content

Support Center